Actuate Therapeutics (ACTU) Stock Chart & Stock Price History $8.12 -0.10 (-1.22%) Closing price 08/15/2025 04:00 PM EasternExtended Trading$8.13 +0.01 (+0.12%) As of 08/15/2025 05:02 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock Actuate Therapeutics Stock Price Performance The Actuate Therapeutics (ACTU) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 6.67%, with a year-to-date return of 2.01%. In the past month, the stock has increased 30.34%, reflecting recent market activity. As of the latest close, Actuate Therapeutics traded at $8.12 with a market cap of $166.22 million and volume of 43,371 shares. Receive ACTU Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Actuate Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+1.37%1 Month Performance+30.34%3 Month Performance-23.03%Year-To-Date Performance+2.01%1 Year Performance-6.67% ACTU Stock Chart for Saturday, August, 16, 2025 ACTU Chart by TradingView Actuate Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/15/2025$8.22$8.12-1.22%$8.23$7.7643,371 shs$166.22 million08/14/2025$8.53$8.22-3.63%$8.99$8.1026,478 shs$168.27 million08/13/2025$8.67$8.53-1.61%$8.70$8.36173,098 shs$174.61 million08/12/2025$8.01$8.67+8.24%$8.67$7.7968,304 shs$177.48 million08/11/2025$8.02$8.01-0.12%$8.28$7.7624,728 shs$163.97 million08/08/2025$8.07$8.02-0.62%$8.33$7.76115,923 shs$164.17 million08/07/2025$8.17$8.07-1.22%$8.41$7.7639,724 shs$165.20 million08/06/2025$7.31$8.17+11.76%$8.43$7.50174,353 shs$167.24 million08/05/2025$7.07$7.31+3.39%$7.33$6.8143,614 shs$149.64 million08/04/2025$7.26$7.07-2.62%$7.32$6.9317,394 shs$144.73 million Get the Latest News and Ratings for ACTU and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Actuate Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 08/01/2025$7.25$7.26+0.14%$7.33$6.7758,619 shs$148.62 million07/31/2025$7.27$7.25-0.28%$7.33$6.7771,714 shs$148.41 million07/30/2025$6.77$7.27+7.39%$7.30$6.70105,022 shs$148.82 million07/29/2025$6.86$6.77-1.31%$6.97$6.6043,054 shs$132.83 million07/28/2025$7.26$6.86-5.51%$7.22$6.5868,187 shs$134.59 million07/25/2025$6.99$7.26+3.86%$7.28$6.49100,376 shs$142.44 million07/24/2025$6.60$6.99+5.91%$7.10$6.45123,332 shs$137.14 million07/23/2025$6.26$6.60+5.43%$6.70$6.22153,864 shs$129.49 million07/22/2025$5.66$6.26+10.60%$6.29$5.5892,586 shs$122.82 million07/21/2025$5.76$5.66-1.74%$5.98$5.4777,677 shs$111.05 million07/18/2025$6.26$5.76-7.99%$6.21$5.7687,198 shs$113.01 million07/17/2025$6.23$6.26+0.48%$7.33$6.00618,575 shs$122.82 million07/16/2025$5.97$6.23+4.36%$6.32$5.9246,688 shs$122.23 million07/15/2025$6.20$5.97-3.71%$6.26$5.9745,608 shs$117.13 million Related Companies DNTH Stock Chart PROK Stock Chart GYRE Stock Chart ABUS Stock Chart ZVRA Stock Chart MGTX Stock Chart TSHA Stock Chart GHRS Stock Chart DAWN Stock Chart KALV Stock Chart Receive ACTU Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Actuate Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ACTU) was last updated on 8/16/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredGenesis 14:13-17 [HIDDEN MEANING?]A mysterious Bible verse from Genesis may hold the key to unlocking what one expert calls an “American birthri...Paradigm Press | SponsoredTrump's New Plan to “Make China Pay”Trump's AI Masterplan Could Crush China The White House just unleashed would could be the most aggressive e...Stansberry Research | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Actuate Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Actuate Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access